TrialClinical drug investigation2012

Besifloxacin ophthalmic suspension 0.6% administered twice daily for 3 days in the treatment of bacterial conjunctivitis in adults and children.

Jesse DeLeon et al.PubMed ↗Publisher ↗

No numbers read from the abstract.